Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
486.44B
Market cap486.44B
Price-Earnings ratio
19.49
Price-Earnings ratio19.49
Dividend yield
2.55%
Dividend yield2.55%
Average volume
9.27M
Average volume9.27M
High today
$203.45
High today$203.45
Low today
$200.81
Low today$200.81
Open price
$202.92
Open price$202.92
Volume
7.70M
Volume7.70M
52 Week high
$207.81
52 Week high$207.81
52 Week low
$140.68
52 Week low$140.68

Stock Snapshot

Johnson & Johnson(JNJ) stock is priced at $201.84, giving the company a market capitalization of 486.44B. It carries a P/E multiple of 19.49 and pays a dividend yield of 2.5%.

On 2025-12-06, Johnson & Johnson(JNJ) stock moved within a range of $200.81 to $203.45. With shares now at $201.84, the stock is trading +0.5% above its intraday low and -0.8% below the session's peak.

Trading volume for Johnson & Johnson(JNJ) stock has reached 7.7M, versus its average volume of 9.27M.

The stock's 52-week range extends from a low of $140.68 to a high of $207.81.

The stock's 52-week range extends from a low of $140.68 to a high of $207.81.

JNJ News

Nasdaq 11h
Johnson & Johnson Reports Durable Remissions With CARVYKTI In CARTITUDE-4 Study

(RTTNews) - Johnson & Johnson (JNJ) announced updated results from the Phase 3 CARTITUDE-4 study, reinforcing the potential of CARVYKTI (ciltacabtagene autoleuc...

Johnson & Johnson Reports Durable Remissions With CARVYKTI In CARTITUDE-4 Study
TipRanks 14h
Nvidia, Microsoft, Super Micro, J&J, McDonald’s: Insider Moves Unveiled!

Insiders have been trading these 5 stocks: ((NVDA)), ((MSFT)), ((SMCI)), ((JNJ)) and ((MCD)). Here is a breakdown of their recent trades and their value. TipRan...

TipRanks 1d
J&J says Inlexzo delivers 74% disease-free survival at one year

Johnson & Johnson announced that new data from the investigational Cohort 4 of the Phase 2b SunRISe-1 study show treatment with gemcitabine intravesical system...

Analyst ratings

59%

of 27 ratings
Buy
59.3%
Hold
37%
Sell
3.7%

More JNJ News

Nasdaq 2d
Validea Detailed Fundamental Analysis - JNJ

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor mod...

Validea Detailed Fundamental Analysis - JNJ
TipRanks 2d
Johnson & Johnson price target raised to $227 from $206 at Guggenheim

Guggenheim raised the firm’s price target on Johnson & Johnson to $227 from $206 and keeps a Buy rating on the shares. After reviewing the firm’s J&J company mo...

Simply Wall St 2d
Is It Too Late To Consider Johnson & Johnson After Its 40.6% 2025 Rally?

Wondering if Johnson & Johnson is still attractively priced at today’s level, or if the big gains are already behind it? Let’s unpack what the numbers are reall...

Is It Too Late To Consider Johnson & Johnson After Its 40.6% 2025 Rally?
Nasdaq 2d
Johnson & Johnson Stock Drops Despite Market Gains: Important Facts to Note

The latest trading session saw Johnson & Johnson (JNJ) ending at $145.97, denoting a -1.24% adjustment from its last day's close. The stock's change was less th...

Johnson & Johnson Stock Drops Despite Market Gains: Important Facts to Note
Nasdaq 3d
Only Six Dow Components With Recent Insider Buying, JNJ is One of Them

The officers and directors of a company tend to have a unique inside view into the business, so when these insiders make purchases, investors are wise to take n...

Only Six Dow Components With Recent Insider Buying, JNJ is One of Them
Nasdaq 4d
Is Most-Watched Stock Johnson & Johnson Worth Betting on Now?

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might aff...

Is Most-Watched Stock Johnson & Johnson Worth Betting on Now?
The Motley Fool 4d
Wall Street's Greatest Dividend Stock -- Which 99% of Investors Have No Clue Exists -- Makes for a Screaming Buy in 2026

This under-the-radar income stock has paid a dividend under all but three U.S. presidents, and its 209-year streak of continuous payouts is 60 years longer than...

Wall Street's Greatest Dividend Stock -- Which 99% of Investors Have No Clue Exists -- Makes for a Screaming Buy in 2026

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.